Trade ALDX anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Aldeyra Therapeutics, Inc. (ALDX) is trading at US$1.52, down 1.62% today as of Aug 28, 11:58 EDT. The company has a market capitalisation of US$91.7M. Over the past 52 weeks, ALDX has traded between US$1.07 and US$5.93. On Syfe you can trade ALDX with $0 commission and add it to your watchlist.
| Previous close | US$1.54 |
|---|---|
| Market cap | US$91.7M |
| 52-week range | US$1.07 – US$5.93 |
| Volume | 277.01K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Aldeyra Therapeutics, Inc.
Aldeyra Therapeutics, Inc. is a biotechnology company, which engages in research and development activities related to general business planning, including raising capital. It focuses on the discovery of therapies designed to treat immune-mediated diseases. The company was founded by Thomas A. Jordan and John E. Dowling on August 13, 2004 and is headquartered in Lexington, MA.
Year: 2014
Aldeyra Therapeutics Seeks FDA Clarification on Reproxalap NDA Meeting Minutes
Jul 16, 10:44 AM · MT Newswires
Aldeyra Therapeutics Insider Bought Shares Worth $418,450, According to a Recent SEC Filing
Jun 5, 8:26 PM · MT Newswires
HC Wainwright Downgrades Aldeyra Therapeutics to Neutral From Buy, Adjusts PT to $2 From $10
Mar 18, 10:43 AM · MT Newswires
Sector Update: Health Care Stocks Fall Late Afternoon
Mar 17, 7:51 PM · MT Newswires
Sector Update: Health Care Stocks Decline Tuesday Afternoon
Mar 17, 6:24 PM · MT Newswires
Aldeyra Therapeutics, Inc. (ALDX) stock is trading at US$1.52, -1.62% from the previous close of US$1.54.
The market cap for Aldeyra Therapeutics, Inc. (ALDX) stock is approximately US$91.7M.
The 52-week high for Aldeyra Therapeutics, Inc. (ALDX) stock is US$5.93.
The 52-week low for Aldeyra Therapeutics, Inc. (ALDX) stock is US$1.07.
Aldeyra Therapeutics, Inc. (ALDX) does not currently pay a dividend.
Stay on top of ALDX
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
